Delivery Order SPE2DB22D6029-SPE2DB25FLVJV

Award Date 6/26/25
Potential Completion Date 6/27/25
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,399.49 firm fixed-price delivery order is for the supply of Albendazole 200 mg tablets. The contract has an ultimate completion date of June 24, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $4,059.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,722,209 tablets of the medication Albendazole 200 mg, with a period of performance through July 8, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $2,503.80 firm fixed-price contract is for the delivery of ALBENDAZOLE 200MG 2S, a pharmaceutical product, with a performance period through June 16, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which allows the company to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,254.87, is for the delivery of 4562877981 ALBENDAZOLE 200 MG TABLET 2S. This is a firm fixed-price delivery order contract with a completion date of November 22, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,590.67, is for the provision of 4,568,705,968 tablets of the medication Albendazole 200 mg. The contract has an ultimate completion date of July 7, 2025. Amerisourcebergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,598.52, is for the delivery of ALBENDAZOLE 200 MG TABLET 2S, a pharmaceutical product. The contract is a Firm Fixed Price type and is not set aside for any particular business category. Amerisourcebergen Drug Corp is the prime contractor, and the contract is associated with the company's...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,050.90 to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,459,090 units of the pharmaceutical product ALBENDAZOLE 200 MG TABLET 2S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ALBENDAZOLE 200 MG TABLET 2S, a medication. The contract is a firm fixed-price delivery order with a ceiling value of $1,507.84 and a completion date of May 16, 2025. The contract is not set aside and is awarded as open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
The U.S. Defense Logistics Agency Troop Support Medical awarded a $5,258.40 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the provision of Albendazole tablets. The contract has a completion date of February 22, 2024 and was awarded on February 21, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albendazole 200 mg tablets. The contract, valued at $1,997.46, has a performance period through January 16, 2025 and was awarded on a Firm Fixed Price basis. This Delivery Order contract is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB25FLVJV
    Delivery Order

This is a $4,149.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ALBENDAZOLE 200 MG TABLET 2S, a pharmaceutical product, with a period of performance through June 27, 2025.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The current delivery order is not designated as a set-aside contract.

Generated 9/25/25, 11:07 AM